Trial intelligence / Profile preview

Phase III comparison of NPF-08 versus Moviprep for bowel preparation before colonoscopy

jRCT2080224608Phase 3Completed

Sponsor
Nihon Pharmaceutical
Start
Mar 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of NPF-08 (3 arms), sponsored by Nihon Pharmaceutical. Primary endpoint: Colonoscopy bowel cleansing efficacy. Started Mar 2019; status: completed.

02

Drugs

NPF-08

Beyond the preview

Go deeper on jRCT2080224608.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080224608.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call